Announcements

As all of the articles published in Cancers (ISSN: 2072-6694) are open access, you have free and unlimited access to the full text of all articles. We welcome you to read our most highly cited papers published in 2023 in the Section “Cancer Pathophysiology”, which are listed below:

1. “Castration-Resistant Prostate Cancer: From Uncovered Resistance Mechanisms to Current Treatments”
by Thi Khanh Le, Quang Hieu Duong, Virginie Baylot, Christelle Fargette, Michael Baboudjian, Laurence Colleaux, David Taïeb and Palma Rocchi
Cancers 2023, 15(20), 5047; https://doi.org/10.3390/cancers15205047
Available online: https://www.mdpi.com/2072-6694/15/20/5047

2. “Resveratrol-Loaded Polymeric Nanoparticles: The Effects of D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS) on Physicochemical and Biological Properties against Breast Cancer In Vitro and In Vivo”
by Paulo George Cavalcante de Freitas, Bruno Rodrigues Arruda, Maria Gabriela Araújo Mendes, João Vito Barroso de Freitas, Mateus Edson da Silva, Tiago Lima Sampaio, Raquel Petrilli and Josimar O. Eloy
Cancers 2023, 15(10), 2802; https://doi.org/10.3390/cancers15102802
Available online: https://www.mdpi.com/2072-6694/15/10/2802

3. “Methods to Evaluate Changes in Mitochondrial Structure and Function in Cancer”
by Brittany P. Rickard, Marta Overchuk, Vesna A. Chappell, Mustafa Kemal Ruhi, Prima Dewi Sinawang, Tina Thuy Nguyen Hoang, Demir Akin, Utkan Demirci, Walfre Franco, Suzanne E. Fenton et al.
Cancers 2023, 15(9), 2564; https://doi.org/10.3390/cancers15092564
Available online: https://www.mdpi.com/2072-6694/15/9/2564

4. “How Does Environmental and Occupational Exposure Contribute to Carcinogenesis in Genitourinary and Lung Cancers?”
by Massimiliano Cani, Fabio Turco, Simona Butticè, Ursula Maria Vogl, Consuelo Buttigliero, Silvia Novello and Enrica Capelletto
Cancers 2023, 15(10), 2836; https://doi.org/10.3390/cancers15102836
Available online: https://www.mdpi.com/2072-6694/15/10/2836

5. “Molecular Alterations in Cutaneous Squamous Cell Carcinoma in Immunocompetent and Immunosuppressed Hosts—A Systematic Review”
by Denise Ann Tsang, Steve Y. C. Tam and Choon Chiat Oh
Cancers 2023, 15(6), 1832; https://doi.org/10.3390/cancers15061832
Available online: https://www.mdpi.com/2072-6694/15/6/1832

6. “Breaking the Invisible Barriers: Unleashing the Full Potential of Immune Checkpoint Inhibitors in Oncogene-Driven Lung Adenocarcinoma”
by Hoi-Hin Kwok, Jiashuang Yang and David Chi-Leung Lam
Cancers 2023, 15(10), 2749; https://doi.org/10.3390/cancers15102749
Available online: https://www.mdpi.com/2072-6694/15/10/2749

7. “Recent Advances in Single-Cell RNA-Sequencing of Primary and Metastatic Clear Cell Renal Cell Carcinoma”
by Adele M. Alchahin, Ioanna Tsea and Ninib Baryawno
Cancers 2023, 15(19), 4734; https://doi.org/10.3390/cancers15194734
Available online: https://www.mdpi.com/2072-6694/15/19/4734

8. “Epidemiology of Neuroendocrine Neoplasms and Results of Their Treatment with [¹⁷⁷Lu]Lu-DOTA-TATE or [¹⁷⁷Lu]Lu-DOTA-TATE and [⁹⁰Y]Y-DOTA-TATE—A Six-Year Experience in High-Reference Polish Neuroendocrine Neoplasm Center”
by Adam Daniel Durma, Marek Saracyn, Maciej Kołodziej, Katarzyna Jóźwik-Plebanek, Beata Dmochowska, Waldemar Kapusta, Wawrzyniec Żmudzki, Adrianna Mróz, Beata Kos-Kudła and Grzegorz Kamiński
Cancers 2023, 15(22), 5466; https://doi.org/10.3390/cancers15225466
Available online: https://www.mdpi.com/2072-6694/15/22/5466

9. “Radiomics Analysis in Characterization of Salivary Gland Tumors on MRI: A Systematic Review”
by Kaijing Mao, Lun M. Wong, Rongli Zhang, Tiffany Y. So, Zhiyi Shan, Kuo Feng Hung and Qi Yong H. Ai
Cancers 2023, 15(20), 4918; https://doi.org/10.3390/cancers15204918
Available online: https://www.mdpi.com/2072-6694/15/20/4918

10. “Disturbances in Nitric Oxide Cycle and Related Molecular Pathways in Clear Cell Renal Cell Carcinoma”
by Corina Daniela Ene, Mircea Tampa, Simona Roxana Georgescu, Clara Matei, Iulia Maria Teodora Leulescu, Claudia Ioana Dogaru, Mircea Nicolae Penescu and Ilinca Nicolae
Cancers 2023, 15(24), 5797; https://doi.org/10.3390/cancers15245797
Available online: https://www.mdpi.com/2072-6694/15/24/5797

11. “Gastric Neuroendocrine Tumors (g-NETs): A Systematic Review of the Management and Outcomes of Type 3 g-NETs”
by Alice Laffi, Andrea Gerardo Antonio Lania, Alberto Ragni, Valentina Di Vito, Alessia Liccardi, Manila Rubino, Franz Sesti, Annamaria Colao, Antongiulio Faggiano and on behalf of the NIKE Group
Cancers 2023, 15(8), 2202; https://doi.org/10.3390/cancers15082202
Available online: https://www.mdpi.com/2072-6694/15/8/2202

12. “Malignant Peritoneal Mesothelioma: An In-Depth and Up-to-Date Review of Pathogenesis, Diagnosis, Management and Future Directions”
by Josh B. Karpes, Raphael Shamavonian, Suzannah Dewhurst, Ernest Cheng, Ru Wijayawardana, Nima Ahmadi and David L. Morris
Cancers 2023, 15(19), 4704; https://doi.org/10.3390/cancers15194704
Available online: https://www.mdpi.com/2072-6694/15/19/4704

13. “The Impact of PSMA PET/CT on Modern Prostate Cancer Management and Decision Making—The Urological Perspective”
by Azik Hoffman and Gilad E. Amiel
Cancers 2023, 15(13), 3402; https://doi.org/10.3390/cancers15133402
Available online: https://www.mdpi.com/2072-6694/15/13/3402

14. “Prognostic Value of SGK1 and Bcl-2 in Invasive Breast Cancer”
by Umaima Al-Alem, Garth H. Rauscher, Qais Al Alem, Andre Kajdacsy-Balla and Abeer M. Mahmoud
Cancers 2023, 15(12), 3151; https://doi.org/10.3390/cancers15123151
Available online: https://www.mdpi.com/2072-6694/15/12/3151

15. “Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis”
by Nico C. Grossmann, Francesco Soria, Tristan Juvet, Aaron M. Potretzke, Hooman Djaladat, Alireza Ghoreifi, Eiji Kikuchi, Andrea Mari, Zine-Eddine Khene, Kazutoshi Fujita et al.
Cancers 2023, 15(5), 1409; https://doi.org/10.3390/cancers15051409
Available online: https://www.mdpi.com/2072-6694/15/5/1409

You are invited to view and submit relevant papers to the journal Cancers.

Cancers Editorial Office